Manufacturers prohibition from limiting pharmacy access to 340B drugs
Manufacturers and wholesale distributors prohibited from limiting pharmacy access to 340B drugs.
Excessive price increases by manufacturers prohibition to generic or off-patent drugs
Health; 340B covered entity reporting requirements modified.
Manufacturers requirement to report and maintain prescription drug prices
340B covered entities reporting requirements modifications and reports to the legislature requirement
Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.
Prescription drugs price increases and reporting requirements provisions
Generic or off-patent drugs; excessive price increases prohibited, attorney general authorized to take action against price increases, sale withdrawal prohibited, prescription drug affordability board and advisory council established, prescription drug cost reviews and remedies provided, and money appropriated.
Commissioner of human services allowed to enter into value-based purchasing arrangements with drug manufacturers.